You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 6, June 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Cognitive Disorders
 •Diagnosis
 •Neurogenetics
 •Movement Disorders
 •Neurology, Other
 •Psychiatry
 •Alert me on articles by topic

Psychiatric and Cognitive Difficulties as Indicators of Juvenile Huntington Disease Onset in 29 Patients

Pascale Ribaï, MD; Karine Nguyen, MD; Valérie Hahn-Barma, MD; Isabelle Gourfinkel-An, MD, PhD; Marie Vidailhet, MD, PhD; Antoine Legout, MD; Catherine Dodé, PhD; Alexis Brice, MD; Alexandra Dürr, MD, PhD

Arch Neurol. 2007;64(6):813-819.

Background  Juvenile Huntington disease (JHD) is a rare clinical entity characterized by an age at onset younger than 20 years. Patients usually have an expansion of more than 60 CAG repeats in the Huntington disease (HD) gene, and the disease is usually inherited from the father. In general, precise age at onset is difficult to assess in HD because of insidious onset and anosognosia. Onset of motor difficulty signs is usually used to define age at onset.

Objectives  To evaluate diagnosis delay in patients with JHD and to analyze the clinical and genetic features of JHD.

Design  Retrospective clinical and genetic review.

Setting  Referral center for HD at Salpêtrière Hospital, Paris, France.

Patients  Twenty-nine patients with HD with onset before or at age 20 years who carried an abnormal CAG repeat expansion in the HD gene.

Results  The mean ± SD delay before diagnosis was 9 ± 6 years (range, 0-21 years). The most remarkable signs at onset were severe psychiatric and cognitive disturbances (19 of 29 [65.5%]); rigidity was absent. Unusual signs at onset included myoclonic head tremor in 3 patients, severe isolated drug or alcohol addiction in 2, psychotic disorder in 1, and difficulty writing in 1. One patient had progressive cerebellar signs associated with cerebellar atrophy on cerebral magnetic resonance imaging before signs suggestive of HD appeared. During the course of the disease, psychiatric disturbances were severe, with at least 1 suicide attempt in 7 of 29 patients. Transmission was maternal in 25% of patients. Forty-six percent of patients with JHD had fewer than 60 CAG repeats; 6 of these patients inherited the disease from their father. Anticipation (mean ± SD, 18 ± 9 vs 25 ± 11 years; P = .27) and age at onset (mean ± SD, 17.14 ± 2.2 vs 13.29 ± 5.5 years; P = .09) was similar in patients with maternal compared with paternal transmission, respectively.

Conclusions  Patients with JHD started showing disease symptoms through nonspecific features, mostly psychiatric and cognitive difficulties. This led to misdiagnosis or diagnosis delay, especially in cases without a familial history of HD. Maternal transmissions and expansions of fewer than 60 CAG repeats were unexpectedly frequent in this series and should not be considered exceptional.


Author Affiliations: Department of Genetics, Cytogenetics, and Embryology (Drs Ribaï, Nguyen, Brice, and Dürr), Fédération de Neurologie (Drs Hahn-Barma and Brice), Federative Institute for Neuroscience Research (Drs Gourfinkel-An, Vidailhet, and Brice), and Pôle d’Epileptologie Clinique (Dr Gourfinkel-An), Salpêtrière Hospital; Department of Neurology, Saint-Antoine Hospital (Dr Vidailhet); and INSERM 679, Neurology and Experimental Therapeutics (Drs Ribaï, Brice, and Dürr), Paris, France; Department of Neurology, Centre Hospitalier du Mans, Le Mans, France (Dr Legout); and Laboratoire de Biochimie et Génétique Moléculaire, Institut Cochin (Dr Dodé), and Salpêtrière Medical School, Pierre and Marie Curie University (Dr Brice), Paris, France.


RELATED ARTICLE

Juvenile-Onset Huntington Disease: A Matter of Perspective
Kevin Biglan and Ira Shoulson
Arch Neurol. 2007;64(6):783-784.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Juvenile-Onset Huntington Disease: A Matter of Perspective
Biglan and Shoulson
Arch Neurol 2007;64:783-784.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.